Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wedlake

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 9, 2016
Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity AssessmentI De Francesco, K Thomas, L Wedlake, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational studyL Wedlake, K Thomas, C McGough, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2009
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndromeL Wedlake, R A'Hern, D Russell, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?L Wedlake, C McGough, C Hackett, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapyC McGough, L Wedlake, C Baldwin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 9, 2016
Intensity-modulated Radiotherapy and Anal Cancer: Clinical Outcome and Late Toxicity AssessmentI De Francesco, K Thomas, L Wedlake, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: An observational studyL Wedlake, K Thomas, C McGough, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2009
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndromeL Wedlake, R A'Hern, D Russell, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?L Wedlake, C McGough, C Hackett, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2008
Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapyC McGough, L Wedlake, C Baldwin, et al.
Pageof 1